
Our guest blogger of the week is Anna Aulette-Root, a Ph.D. candidate and lecturer at the University of Cape Town in South Africa. Aulette-Root has done extensive research on the global health epidemic of HIV and gendered violence.
Activists, practitioners, and scholars in South Africa are currently looking at the significant role gender-based violence (GBV) plays in the spread of HIV. In contexts outside of South Africa, especially in the Global North, GBV is not commonly understood as a health problem. In the USA, for example, GBV is often thought of as a woman’s rights issue, or a psychological problem in men, or a problem best left to the criminal justice system. In the USA, GBV is not usually viewed as being a result of a combination of the above, and making the leap in understanding GBV as a health issue is virtually unheard of.
Certainly, in South Africa we see GBV as a social and human rights issue, but we pay close attention to GBV as a health issue. GBV is a problem that impacts the healthcare system in many ways and, importantly, it is an issue that impacts the health of individuals in South Africa and around the globe. Before we look at how GBV creates health problems, it is important to understand what exactly GBV is.
The term ‘gender-based violence’ encompasses any violence where gender plays a role (and if you think about this carefully, the argument could be made that any violence is gender-based). However, it is understood that this term includes violence such as intimate partner violence, domestic violence, physical abuse, psychological abuse, coercive sex, rape, economic violence, and intimate femicide. This list, for sure, is incomplete and many other forms of gendered violence exist. Perhaps the most well-known type of gender-based violence is domestic violence or intimate partner violence, in which (in heterosexual relationships) a man or boy is doing the abusing and a girl or woman is surviving the abuse. GBV/violence against women occurs because of the way gender is constructed (men have power over women) and also as a way of keeping the status quo (men use violence as a way of maintaining power over women). So what exactly are the health consequences of GBV?
GBV is a health concern in terms of the physical and psychological damage incurred by survivors. GBV has also been implicated as being intimately linked to the global HIV epidemic. We know that between 10%-60% of all women world-wide, will experience GBV in their lifetime.[1] We also know that the number of women living with HIV has been on the increase since the 1990s[2] and is now listed as the leading cause of death and disease in women world-wide. [3] Numerous studies have established and a number of scholars have written about direct as well as indirect links between GBV and HIV infection.[4] [5]
In its most graphic expression, violent acts such as rape or coercive sex may lead to HIV infection due to women’s bodies being ripped and torn—wounds make entryways for the virus. In addition, women in violent partnerships often find it difficult or even impossible to refuse sexual advances; persuade their partner to stop cheating; or seek treatment for abuse or STIs.2 And in terms of using condoms (which is the global message we all receive in curbing the spread of HIV), imagine the difficulties in insisting on or even negotiating condom use with a partner who is abusive? If an abuser is unwilling to stop their violence, it is likely they are also unwilling to heed the request of their partner to use condoms.2
So what does all of this mean and what can be done? The fact southern Africa has reportedly been particularly hard-hit in the HIV pandemic means that a great deal of attention, focus, and work has been done in South Africa (as well as in other nations on the continent) in finding solutions to this health crisis. What scholars, practitioners, and activists in South Africa have found is that: unequal power between men and women in intimate relationships and the way that gender is constructed is furthering the spread of HIV and therefore, GBV is more than simply a social or human rights problem—it is a major health problem as well. If gender is constructed such that part of being a man means being violent toward woman partners and part of being a woman means being attracted to violent men—something has to give. South African scholars, practitioners, and activists have called for a fundamental change in the ways in which we go about educating people, intervening in, and treating people living with HIV. Rather than focusing on behaviors such as ‘abstaining, being faithful, and condomizing,’ our focus should be on transforming the ways in which we are ‘allowed’ to be men and women. This means envisioning a world in which there is no gender inequality; where being a ‘manly’ man might include caring for partners and children; where being a ‘good’ woman might include being strong and vocal; and where there is less need for recognizing so-called differences between the genders—for we are all human.
South Africans have paved the way for this goal of eliminating GBV, HIV, and transforming gender—these messages must now find their ways out to the rest of the world.
[1] Ellsberg, M. & Heise, L. (2005).
Researching Violence Against Women: A Practical Guide for Researchers and Activists. Washington, DC, USA: World Health Organization.
[2] World Health Organization (2009). Women and Health: Today’s Evidence Tomorrow’s Agenda. Geneva, Switzerland: WHO.
[3] Ribeiro, P., Jacobsen, K., Mathers, C. & Garcia-Moreno, C. (2008). Priorities for women’s health from the Global Burden of Disease study. International Journal of Gynaecology and Obstetrics, 102, 82–90.
[4] Jewkes, R. & Morrell, R. (2010). Gender and sexuality: Emerging perspectives from the heterosexual
epidemic in South Africa and implications for HIV risk and prevention. Journal of the International AIDS Society, 13, 6-17.
[5] Jewkes, R. & Morrell, R. (2010). Gender and sexuality: Emerging perspectives from the heterosexual
epidemic in South Africa and implications for HIV risk and prevention. Journal of the International AIDS Society, 13, 6-17.